My Portfolio
+
LINK YOUR PORTFOLIO

Arvinas Inc ARVN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 06/02/26 EDT
7.70quote price arrow down-0.30 (-3.75%)
Volume
1,197,632
52 week range
6.06 - 14.51
Loading...
  • Open7.88
  • Day High7.98
  • Day Low7.56
  • Prev Close7.70
  • 52 Week High14.51
  • 52 Week High Date03/10/26
  • 52 Week Low6.06
  • 52 Week Low Date08/07/25

Latest On Arvinas Inc

Key Stats

  • Market Cap496.813M
  • Shares Out64.52M
  • 10 Day Average Volume0.80M
  • Dividend-
  • Dividend Yield-
  • Beta1.75

Latest On Arvinas Inc

KEY STATS

  • Open7.88
  • Day High7.98
  • Day Low7.56
  • Prev Close7.70
  • 52 Week High14.51
  • 52 Week High Date03/10/26
  • 52 Week Low6.06
  • 52 Week Low Date08/07/25
  • Market Cap496.813M
  • Shares Out64.52M
  • 10 Day Average Volume0.80M
  • Dividend-
  • Dividend Yield-
  • Beta1.75

RATIOS/PROFITABILITY

  • EPS (TTM)-3.26
  • P/E (TTM)-2.36
  • Fwd P/E (NTM)-2.51
  • EBITDA (TTM)-250.70M
  • ROE (TTM)-42.28%
  • Revenue (TTM)89.40M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-247.54%
  • Debt To Equity (MRQ)0.08%

EVENTS

  • Earnings Date08/04/2026(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Arvinas, Inc. is a clinical-stage biotechnology company. The Company, through its PROteolysis Targeting Chimera (PROTAC) protein degrader platform, is pioneering the development of protein degradation therapies designed to harness the body's natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. It is progressing multiple investigational drugs through clinical development programs, including vepdegestrant, ARV-393, ARV-102...
Briggs Morrison M.D.
Independent Chairman of the Board
Randy Teel Ph.D.
President, Chief Executive Officer, Director
Andrew Saik
Chief Financial Officer, Treasurer, Principal Financial Officer
Address
5 Science Park
New Haven, CT
06511-1966
United States